p38MAPK and NF-κB inhibition resulted in lower ADAM10 expression, which indicate that TNF-α upregulated ADAM10 expression through the p38MAPK/NF-κB pathway in patients with PCa. The gene discussed is NFKB1; the disease is posterior cortical atrophy.